Clinical Trial Update: Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sequential CD19/CD22 CAR-T cell therapy after autologous stem cell transplant in Diffuse large B-cell lymphoma; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CD19/CD22 CAR-T cell therapy

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Large B-cell Lymphoma, CAR T Cell Therapy | Phase 2 | Status: COMPLETED